Return to homepagePandemic Pact

Genomic surveillance SARS-CoV2, preliminary phase

  • Funded by State Secretariat for Education, Research and Innovation (SERI)
  • Total publications:0 publications

Grant number: 0142004471

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $1,320,632.57

  • Funder

    State Secretariat for Education, Research and Innovation (SERI)

  • Principal Investigator

    Bourqui-Pittet Martine

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The course of the pandemic due to the Coronavirus SARS-CoV 2 is influenced by the virus strains in circulation. Certain strains may have decisive epidemiological characteristics such as greater contagiousness, cause more serious developments of the disease, reduce the effectiveness of a vaccine, etc. In December 2020, strains of the so-called English variant or Alpha variant began to be in circulation and suggested a more contagious strain. It was urgent to set up a genomic surveillance system by sequencing a certain number of coronavirus-positive samples. ETHZ, through the Science Task Force and Professor Stadler, have made their laboratories, resources and skills available for the implementation ...